EJNMMI Physics

Table 2 Patient characteristics

From: Impact of different models based on blood samples and images for bone marrow dosimetry after ¹⁷⁷Lu-labeled somatostatin-receptor therapy

	All patients (n = 59)
Gender, n (%)
Male	38 (64.4)
Female	21 (35.6)
Age at first injection
Median [min–max]	67 [26–83]
Site of primary tumor, n (%)
Small intestine	51 (86.4)
Pancreas	5 (8.5)
Stomach	1 (1.7)
Unknown	2 (3.4)
Injected activity (MBq)
Median [min–max]	7457.2 [3516–7989]

Back to article page